HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hala Gali-Muhtasib Selected Research

thymoquinone

3/2022Thymoquinone Radiosensitizes Human Colorectal Cancer Cells in 2D and 3D Culture Models.
7/2021Therapeutic potential of thymoquinone in combination therapy against cancer and cancer stem cells.
5/2021Thymoquinone anticancer activity is enhanced when combined with royal jelly in human breast cancer.
5/2021Corrigendum: Synthesis of Novel Hybrids of Thymoquinone and Artemisinin with High Activity and Selectivity Against Colon Cancer.
8/2020Thymoquinone induces apoptosis and DNA damage in 5-Fluorouracil-resistant colorectal cancer stem/progenitor cells.
6/2020Thymoquinone synergizes with arsenic and interferon alpha to target human T-cell leukemia/lymphoma.
1/2020Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization.
9/2019Thymoquinone enhances the anticancer activity of doxorubicin against adult T-cell leukemia in vitro and in vivo through ROS-dependent mechanisms.
1/2019Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells.
1/2018Thymoquinone-based nanotechnology for cancer therapy: promises and challenges.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hala Gali-Muhtasib Research Topics

Disease

38Neoplasms (Cancer)
03/2022 - 05/2004
22Colonic Neoplasms (Colon Cancer)
01/2022 - 07/2004
10Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 10/2004
5Hypoxia (Hypoxemia)
01/2014 - 05/2004
3Breast Neoplasms (Breast Cancer)
05/2021 - 01/2014
3Carcinogenesis
11/2012 - 03/2005
3Aberrant Crypt Foci
04/2008 - 06/2007
2Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
06/2020 - 09/2019
2Neoplasm Metastasis (Metastasis)
01/2014 - 07/2013
2Inflammation (Inflammations)
07/2011 - 08/2010
1Papillomavirus Infections
07/2021
1Anus Neoplasms (Anal Cancer)
07/2021
1Triple Negative Breast Neoplasms
01/2020
1Myxoid Liposarcoma
10/2015
1Liposarcoma
10/2015
1Ataxia Telangiectasia (Louis Bar Syndrome)
11/2010
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
06/2010
1Papilloma (Papillomatosis)
04/2008
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2008

Drug/Important Bio-Agent (IBA)

18thymoquinoneIBA
03/2022 - 10/2004
10Pharmaceutical PreparationsIBA
08/2020 - 01/2006
5Reactive Oxygen Species (Oxygen Radicals)IBA
07/2014 - 07/2008
4PhytochemicalsIBA
12/2015 - 03/2009
4Antineoplastic Agents (Antineoplastics)IBA
07/2013 - 10/2004
3Fluorouracil (Carac)FDA LinkGeneric
08/2020 - 01/2017
3Tannic AcidFDA Link
10/2015 - 03/2007
3SesquiterpenesIBA
07/2013 - 04/2008
3LactonesIBA
07/2013 - 04/2008
31,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA
04/2008 - 06/2007
3Complex MixturesIBA
04/2008 - 06/2007
2AntioxidantsIBA
01/2022 - 01/2014
2MicroRNAs (MicroRNA)IBA
07/2021 - 09/2019
2artemisinin (artemisinine)IBA
05/2021 - 01/2017
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2020 - 08/2014
2Therapeutic UsesIBA
02/2019 - 04/2008
2AlkaloidsIBA
02/2017 - 11/2011
2quindoxinIBA
01/2014 - 07/2004
2CarcinogensIBA
11/2012 - 04/2008
2Proteins (Proteins, Gene)FDA Link
11/2010 - 01/2007
2QuinoxalinesIBA
11/2010 - 05/2004
2salograviolide AIBA
04/2008 - 04/2008
2Dimenhydrinate (DMH)FDA LinkGeneric
01/2008 - 06/2007
1Radiation-Sensitizing AgentsIBA
03/2022
1Polysaccharides (Glycans)IBA
01/2022
1fucoidanIBA
01/2022
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
01/2022
1AlginatesIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
07/2021
1RNA (Ribonucleic Acid)IBA
07/2021
1royal jellyIBA
05/2021
1Interferon-alpha (Interferon Alfa)IBA
06/2020
1ArsenicIBA
06/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
09/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2019
1Heterocyclic Compounds (Compounds, Heterocyclic)IBA
02/2019
1benzonitrileIBA
02/2019
1DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
01/2018
13- (4'- hydroxy- 3'- adamantylbiphenyl- 4- yl)acrylic acidIBA
01/2018
1RetinoidsIBA
01/2018
1artesunic acidIBA
01/2017
1EstersIBA
01/2017
1cabazitaxelFDA Link
01/2016
1Docetaxel (Taxotere)FDA Link
01/2016
1taxaneIBA
01/2016
1Paclitaxel (Taxol)FDA LinkGeneric
01/2016
1tanespimycin (17AAG)IBA
10/2015
1Heat-Shock Proteins (Heat-Shock Protein)IBA
10/2015
15- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA
10/2015
1A-Form DNA (A-DNA)IBA
10/2015
1TanninsIBA
10/2015
1Phosphotransferases (Kinase)IBA
08/2014
1Chelating AgentsIBA
07/2014
1CopperIBA
07/2014
1MetalsIBA
07/2014
1N,N,N',N'- tetrakis(2- pyridylmethyl)ethylenediamineIBA
07/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2014
1ethyleneIBA
07/2013
1phosphine (phosphane)IBA
07/2013
1ProdrugsIBA
07/2013
1GoldIBA
07/2013
1PanobinostatIBA
12/2012
1Small Interfering RNA (siRNA)IBA
12/2012
1Death-Associated Protein KinasesIBA
12/2012
1Cyclin D1IBA
11/2012
1parthenolideIBA
11/2012
1plitidepsin (aplidine)IBA
11/2011
1TubulinIBA
11/2011
1TrabectedinIBA
11/2011
1Biological ProductsIBA
11/2011
1NF-kappa B (NF-kB)IBA
07/2011
1Caspase 2IBA
11/2010
1alpha-terpineolIBA
06/2010

Therapy/Procedure

14Therapeutics
07/2021 - 05/2004
5Drug Therapy (Chemotherapy)
09/2019 - 01/2006
2Radiotherapy
03/2022 - 07/2021
1Intraperitoneal Injections
08/2020
1Chemoprevention
11/2012
1Traditional Medicine (Folk Remedies)
08/2010
1Complementary Therapies (Alternative Medicine)
03/2009
1Subcutaneous Injections
04/2008